Coinage metal complexes against breast cancer

Area of Science:

• Medicinal Chemistry
• Oncology
• Pharmacology

Background:

• Breast cancer remains a leading cause of cancer mortality in women globally.
• Cisplatin and carboplatin (platinum-based drugs) show promise for breast tumors, especially aggressive subtypes.
• There is a critical need for novel breast cancer therapies with improved efficacy and reduced toxicity.

Purpose of the Study:

• To review recent advancements in coinage metal-based anticancer drugs.
• To focus on the biological and mechanistic aspects of these novel agents.
• To evaluate their potential as targeted breast cancer therapies.

Main Methods:

• Literature review of studies published up to 2012.
• Analysis of biological activity and mechanistic data for copper, silver, and gold complexes.
• Comparison of coinage metal complexes with traditional platinum-based chemotherapy.

Main Results:

• Coinage metal complexes demonstrate enhanced selectivity for breast cancer cells.
• These agents exhibit fewer and less severe side effects compared to platinum drugs.
• Potential for treating multidrug-resistant and triple-negative breast cancer subtypes.

Conclusions:

• Coinage metal complexes represent a promising new class of anticancer drugs for breast cancer.
• Further research into their biological and mechanistic properties is warranted.
• These compounds offer a potential alternative to platinum-based chemotherapy with an improved safety profile.